Ke-Tao Jin (Ketao Jin)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Molecularly Imprinted

Cerebral Ischemia

Top Venues

Nanomedicine (London, England)

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Changming Dong, Xuebin Yu, Ke-Tao Jin, Jun Qian
Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective. Nanomedicine (London, England) 18 (30) (2024)
Changming Dong, Xuebin Yu, Ke-Tao Jin, Jun Qian
Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective. Nanomedicine (London, England) 18 (30) (2024)
Shibing Wang, Xue Yang, Ying-Yu Ma, Junjie Wu, Ke-Tao Jin, Ruibo Zhao, Hai Zou, Xiao-Zhou Mou
An engineered self-biomineralized oncolytic adenovirus induces effective antitumor immunity and synergizes with immune checkpoint blockade. Cancer immunology research (2024)
Changming Dong, Xuebin Yu, Ke-Tao Jin, Jun Qian
Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective. Nanomedicine (London, England) 18 (30) (2024)
Changming Dong, Xuebin Yu, Ke-Tao Jin, Jun Qian
Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective. Nanomedicine (London, England) (2024)
Min Chen, Huanrong Lan, Shiya Yao, Ke-Tao Jin, Yun Chen
Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors. Cancers 15 (7) (2023)
Xingliang Fang, Huanrong Lan, Ke-Tao Jin, Daojun Gong, Jun Qian
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review. Cancers 14 (16) (2022)
Ke-Tao Jin, Chunsen Mao, Lin Chen, Lude Wang, Yuyao Liu, Jianlie Yuan
Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma. Cancers 13 (2) (2021)
Ke-Tao Jin, Wen-Lin Du, Yu-Yao Liu, Huan-Rong Lan, Jing-Xing Si, Xiao-Zhou Mou
Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements. Cancers 13 (4) (2021)
Li-Feng Hu, Huan-Rong Lan, Xue-Min Li, Ke-Tao Jin
A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities. Oxidative medicine and cellular longevity 2021 (2021)
Ke-Tao Jin, Wen-Lin Du, Huan-Rong Lan, Yu-Yao Liu, Chun-Sen Mao, Jin-Lin Du, Xiao-Zhou Mou
Development of humanized mouse with patient-derived xenografts for cancer immunotherapy studies: A comprehensive review. Cancer science 112 (7) (2021)
Huanrong Lan, Yuyao Liu, Jinlong Liu, Xuanwei Wang, Zhonghai Guan, Jinlin Du, Ke-Tao Jin
Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer. Molecular pharmaceutics 18 (3) (2021)